Curis, Inc. (CRIS)
0.4071
-0.10
(-19.86%)
USD |
NASDAQ |
Oct 16, 16:00
0.4174
+0.01
(+2.53%)
After-Hours: 20:00
Curis Max Drawdown (5Y) : 99.98% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.98% |
| August 31, 2026 | 99.96% |
| July 31, 2026 | 99.88% |
| June 30, 2026 | 99.88% |
| May 31, 2026 | 99.85% |
| April 30, 2026 | 99.85% |
| March 31, 2026 | 99.84% |
| February 28, 2026 | 99.75% |
| January 31, 2026 | 99.75% |
| December 31, 2025 | 99.70% |
| November 30, 2025 | 99.67% |
| October 31, 2025 | 99.64% |
| September 30, 2025 | 99.64% |
| August 31, 2025 | 99.64% |
| July 31, 2025 | 99.64% |
| June 30, 2025 | 99.64% |
| May 31, 2025 | 99.64% |
| April 30, 2025 | 99.64% |
| March 31, 2025 | 99.35% |
| February 28, 2025 | 99.10% |
| January 31, 2025 | 99.06% |
| December 31, 2024 | 99.06% |
| November 30, 2024 | 98.86% |
| October 31, 2024 | 98.81% |
| September 30, 2024 | 98.81% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.81% |
| July 31, 2024 | 98.81% |
| June 30, 2024 | 98.81% |
| May 31, 2024 | 98.81% |
| April 30, 2024 | 98.81% |
| March 31, 2024 | 98.81% |
| February 29, 2024 | 98.81% |
| January 31, 2024 | 98.81% |
| December 31, 2023 | 98.81% |
| November 30, 2023 | 98.81% |
| October 31, 2023 | 98.81% |
| September 30, 2023 | 97.97% |
| August 31, 2023 | 97.11% |
| July 31, 2023 | 97.11% |
| June 30, 2023 | 97.11% |
| May 31, 2023 | 97.11% |
| April 30, 2023 | 97.11% |
| March 31, 2023 | 97.11% |
| February 28, 2023 | 97.11% |
| January 31, 2023 | 97.11% |
| December 31, 2022 | 97.11% |
| November 30, 2022 | 96.67% |
| October 31, 2022 | 96.67% |
| September 30, 2022 | 96.67% |
| August 31, 2022 | 96.67% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Agenus, Inc. | 98.84% |
| Amgen, Inc. | 24.86% |
| Anika Therapeutics, Inc. | 83.15% |
| BioCryst Pharmaceuticals, Inc. | 79.10% |
| Imunon, Inc. | 99.49% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -115.65 |
| Beta (5Y) | 3.115 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 109.8% |
| Historical Sharpe Ratio (5Y) | -0.7693 |
| Historical Sortino (5Y) | -1.506 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 52.00% |